This study summarizes phenotypic features of patients with JPI and shows that treatment of JPI patients with mTOR inhibitors reduces disease progression, reduces need for colectomy and corrects hypoalbuminemia and anemia as surrogate markers of epithelial barrier dysfunction and bleeding. Here, MTOR is linked to anemia.